vinyl alcohol polymer

Small moleculeexperimental

Clinical trial activity

5 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Dec 1, 2008 (NCT00814333)

Timeline

2010s

  1. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

C=CO
Mol. weight
44.05 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Single Stereoisomer
Inorganic
No
Polymer
Yes

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • hypotears
  • hypotears pf
  • liquifilm
  • liquifilm
  • liquifilm tears
  • liquifilm tears
  • polyalc
  • polyvinyl alcohol
  • polyvinyl alcohol
  • polyvinyl alcohol
  • polyvinyl alcohol
  • polyvinyl alcohol
  • polyvinyl alcohol
  • polyvinyl alcohol
  • polyvinyl alcohol, unspecified
  • sno tears
  • vinyl alcohol polymer

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05490381Phase 1Jan 5, 2023Guerbet, University of Washington
NCT02964260N/AMay 1, 2016Shantou University, Sun Yat-Sen University
NCT02762266Phase 3Feb 27, 2016National Cancer Institute (NCI), Stanford University
NCT01381211Phase 2Sep 1, 2011Ghent University
NCT00814333N/ADec 1, 2008Pfizer, University of Kansas
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Ghent UniversityAcademic/Hospital1112011
GuerbetFor profit1012023
National Cancer Institute (NCI)Government1012016
PfizerFor profit1012008
Shantou UniversityAcademic/Hospital1012016
Stanford UniversityAcademic/Hospital1112016
Sun Yat-Sen UniversityAcademic/Hospital1112016
University of KansasAcademic/Hospital1112008
University of WashingtonAcademic/Hospital1112023
9 organizations
Page 1 / 1